Chapter 140

The news about Joy Biopharma, the biopharmaceutical company, buying Young Conglomerate made headlines in the financial papers the next day. The article gave its condolences to Young Conglomerate and wished the best to Joy Biopharma and its future endeavors. However, no one was prepared to find out about the shocking changes in Young Conglomerate after the acquisition, or the lack thereof. Apart from a few upper or middle-level dismissals, there were barely any changes for the other positions. Even the chairman of the board was still the same person. It was still Braxton Young. Did they just buy their own company shares? Joy Biopharma’s Miss Yard took up the role as the managing director of Young Conglomerate, giving herself the highest position in the company. Upon arrival at the company, she immediately set about reorganizing the company without consulting Braxton at all. By lunchtime, Braxton realized that he was just a puppet. He was not happy about it. When he found Mich